Drug Shortage Report for MINT-ZOLMITRIPTAN
Report ID | 113199 |
Drug Identification Number | 02419521 |
Brand name | MINT-ZOLMITRIPTAN |
Common or Proper name | zolmitriptan |
Company Name | MINT PHARMACEUTICALS INC |
Market Status | MARKETED |
Active Ingredient(s) | ZOLMITRIPTAN |
Strength(s) | 2.5MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 6 count blisters |
ATC code | N02CC |
ATC description | ANTIMIGRAINE PREPARATIONS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2020-04-24 |
Estimated end date | Unknown |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2020-04-25 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 6575 DAVAND DRIVE MISSISSAUGA, ONTARIO CANADA L5T 2M3 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v2 | 2020-04-25 | French | Compare |
v1 | 2020-04-25 | English | Compare |
Showing 1 to 2 of 2